Mechanism of enhanced oral availability of CYP 3A4 concentration and mechanism-based inactivation by furanocoumarins. - Schmiedlin-Ren ,P,.; Edwards ,D.J,.; Fitzsimmons ,M.E,.; He ,K,.; Lown ,K.S,.; Woster ,P.M et al.. (Drug Metab. Disp., 1997)